Hemfosa acquires office portfolio in Espoo and Helsinki at a value of approximately MSEK 465

Report this content

Hemfosa has acquired an office portfolio, with a majority of community services sector tenants, at an underlying property value of approximately MSEK 465. With this acquisition and the transaction conducted in June, Hemfosa is strengthening its presence in the Helsinki area, which is in line with the company’s strategic focus on the Finnish market.

Hemfosa har acquired five properties in which the City of Espoo and the City of Helsinki account for a combined total of 82 percent of the rental value. Four properties are located in Espoo and one property is in Helsinki, and all of them are well located with excellent transport connections. The total leasable area amounts to approximately 21,100 sqm. The leasing rate is 85 percent and the remaining lease is 5.7 years. Annual rental income amounts to MEUR 4.5, corresponding to approximately MSEK 47.5. Ownership of the properties was transferred on July 1, 2019.

“Through yet another transaction in the Helsinki area, we are strengthening Hemfosa’s position as a community services property owner in Finland, fully in line with our focus on the Finnish market. These properties also have a development potential with opportunities for increased leasing and future projects,” comments Anna Alsborger, Head of Transactions at Hemfosa.

For further information, please contact:  

Anna Alsborger, Head of Transactions, mobile +46 70 979 45 72, anna.alsborger@hemfosa.se

About Hemfosa Fastigheter

Hemfosa is a Swedish property company focused on community service properties in the Nordic region, with the Swedish state and municipalities as its largest tenants. This provides stable revenue flows and a healthy yield. Hemfosa also aims to create value through active participation in the transaction market. At March 31, 2019, Hemfosa owned properties with a total property value of approximately SEK 37 billion. The company’s ordinary share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se